サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1795299

オプトジェネティクスの世界市場

Optogenetics

出版日
ページ情報
英文 107 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.53円
オプトジェネティクスの世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 107 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オプトジェネティクスの世界市場は2030年までに21億米ドルに達する見込み

2024年に7億5,770万米ドルと推定されるオプトジェネティクスの世界市場は、2024年から2030年にかけてCAGR 18.7％で成長し、2030年には21億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるタイプIオプトジェネティクスは、CAGR 17.0％を記録し、分析期間終了時には13億米ドルに達すると予測されます。タイプIIオプトジェネティクスセグメントの成長率は、分析期間中CAGR 21.7%と推定されます。

米国市場は1億9,920万米ドルと推定、中国はCAGR17.8％で成長予測

米国のオプトジェネティクス市場は、2024年に1億9,920万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR17.8%で推移し、2030年には予測市場規模3億2,740万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ17.0％と16.4％と予測されています。欧州では、ドイツがCAGR約13.9%で成長すると予測されています。

世界のオプトジェネティクス市場- 主要動向と促進要因のまとめ

オプトジェネティクスは神経科学と細胞研究をどのように変革するか？

オプトジェネティクスは、遺伝子組み換え細胞（特に神経細胞）の細胞活動を光で制御する高度な技術です。この方法により、研究者は光感受性タンパク質を用いて特定の細胞をリアルタイムで操作することができ、神経回路やシグナル伝達経路をこれまでにない方法で制御することができます。この手法により、脳活動の詳細なマッピングが可能になり、パーキンソン病、てんかん、うつ病などの疾患に関連する複雑な神経学的行動が理解できるようになり、神経科学に革命が起きています。

脳研究にとどまらず、オプトジェネティクスは心臓病学、疼痛研究、視力回復の分野でも研究されています。その精度とスピードは、多くの状況において、薬理学的刺激や電気刺激よりも効果的です。定義された細胞集団をターゲットにすることで、オプトジェネティクスは生物学的経路の選択的活性化または阻害をサポートし、研究者に微細なレベルで機能をプローブするツールを提供します。

どのような技術革新が応用範囲を広げていますか？

遺伝子工学、ウイルスベクター設計、光送達システムにおける最近の動向は、光遺伝学的手法の有用性を高めています。新しい光感受性イオンチャネルやオプシンは、異なる波長や強度で活性化するように設計されており、より深い組織への浸透や熱損傷の低減を可能にしています。これらには、生体内での使用に適した赤色シフトや近赤外応答性オプシンが含まれます。

小型化された光ファイバーシステム、ワイヤレス光伝送装置、オプトエレクトロニクスインプラントにより、自由に動く動物モデルでの長期的研究が可能になっています。二光子顕微鏡、電気生理学、機能的MRIとの統合は、マルチモーダルな実験をサポートしています。CRISPRやウイルスベクターシステムの進歩により、遺伝子発現のターゲティングが改善され、オフターゲット効果が減少し、中枢神経系以外への応用が拡大しています。

どこで導入が進み、どの分野で研究が加速しているか？

ニューロサイエンスの学術研究所、製薬研究機関、トランスレーショナルメディシンプログラムでは、オプトジェネティクスの採用が拡大しています。北米と欧州は研究強度でリードしており、アジア太平洋諸国は神経生物学と生物工学への投資を急速に増やしています。大学や研究機関は、精神疾患や神経変性疾患のモデル化や、ブレインマシンインターフェースの探求に、オプトジェネティクスを応用しています。

網膜の再生、心臓のリズム調節、免疫細胞のシグナル伝達研究などが、新たな関心分野となっています。バイオテクノロジー企業は、前臨床薬物スクリーニング、行動分析、バイオセンサー開発の一環として光遺伝学的ツールを研究しています。技術的な複雑さにもかかわらず、特に視力回復や治療抵抗性の神経疾患への対応など、臨床応用への関心が高まっています。

オプトジェネティクス市場の成長は、いくつかの要因によって牽引されています。

オプトジェネティクス市場の成長は、神経科学研究の増加、精密細胞制御ツールの採用増加、遺伝子導入および光活性化技術における継続的な技術革新などの要因によってもたらされます。アカデミックおよびトランスレーショナルな環境における高度な神経刺激法の需要が、より効率的でカスタマイズ可能な光遺伝学的ツールの開発を後押ししています。

オプトジェネティクスをライブイメージング、行動アッセイ、電気生理学と統合する能力は、システム生物学における役割を強化しています。神経回路マッピング、精神疾患研究、視力回復技術への投資の高まりが市場拡大を後押ししています。オプシン感度、発現制御、植え込み型光システムの改良は、実世界での応用可能性を広げ、研究と初期臨床の両領域で勢いを持続させています。

セグメント

オプトジェネティクスタイプ（タイプI、タイプII）

調査対象企業の例

  • Addgene
  • Applied Genetic Technologies Corp.
  • Bruker Corporation
  • Bionic Sight LLC
  • Campden Instruments
  • Circuit Therapeutics Inc.
  • Cobolt Inc.
  • Coherent Inc.
  • Danaher Corporation
  • Elliot Scientific Ltd.
  • GenSight Biologics
  • GenScript Biotech Corporation
  • Hubner Photonics Inc.
  • Inscopix
  • Jackson Laboratory
  • Judges Scientific Plc
  • Laserglow Technologies
  • Lumentum Holdings Inc.
  • Merck KGaA
  • Mightex Systems

AIインテグレーション

検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革します。

Global Industry Analystsは、一般的なLLMや業界別SLMにクエリーするのではなく、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP37596

Global Optogenetics Market to Reach US$2.1 Billion by 2030

The global market for Optogenetics estimated at US$757.7 Million in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 18.7% over the analysis period 2024-2030. Type I Optogenetics, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Type II Optogenetics segment is estimated at 21.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$199.2 Million While China is Forecast to Grow at 17.8% CAGR

The Optogenetics market in the U.S. is estimated at US$199.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$327.4 Million by the year 2030 trailing a CAGR of 17.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 16.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.

Global Optogenetics Market - Key Trends & Drivers Summarized

How Is Optogenetics Transforming Neuroscience and Cellular Research?

Optogenetics is an advanced technique that uses light to control cellular activity in genetically modified cells, particularly neurons. This method allows researchers to manipulate specific cells in real time using light-sensitive proteins, offering unprecedented control over neural circuits and signaling pathways. The approach is revolutionizing neuroscience by enabling detailed mapping of brain activity and understanding of complex neurological behaviors, including those linked to disorders such as Parkinson’s disease, epilepsy, and depression.

Beyond brain research, optogenetics is being explored in cardiology, pain studies, and vision restoration. Its precision and speed make it more effective than pharmacological or electrical stimulation in many contexts. By targeting defined cell populations, optogenetics supports selective activation or inhibition of biological pathways, providing researchers with a tool to probe function at a fine-grained level.

What Technological Innovations Are Expanding the Application Scope?

Recent developments in genetic engineering, viral vector design, and light delivery systems are enhancing the utility of optogenetic methods. New light-sensitive ion channels and opsins are being engineered for activation at different wavelengths and intensities, enabling deeper tissue penetration and reduced thermal damage. These include red-shifted and near-infrared responsive opsins suited for in vivo use.

Miniaturized fiber-optic systems, wireless light delivery devices, and optoelectronic implants are enabling long-term studies in freely moving animal models. Integration with two-photon microscopy, electrophysiology, and functional MRI is supporting multimodal experiments. Advances in CRISPR and viral vector systems are improving gene expression targeting, reducing off-target effects, and expanding applicability beyond the central nervous system.

Where Is Adoption Growing and Which Fields Are Accelerating Research?

Adoption of optogenetics is expanding within academic neuroscience laboratories, pharmaceutical research institutions, and translational medicine programs. North America and Europe lead in research intensity, while Asia-Pacific countries are rapidly increasing investment in neurobiology and bioengineering. Universities and research institutes are applying optogenetics to model psychiatric and neurodegenerative disorders and to explore brain-machine interfaces.

Emerging areas of interest include retinal regeneration, cardiac rhythm modulation, and immune cell signaling studies. Biotechnology firms are investigating optogenetic tools as part of preclinical drug screening, behavioral analysis, and biosensor development. Despite technical complexity, interest in clinical translation is growing, especially for restoring vision and addressing treatment-resistant neurological conditions.

Growth in the Optogenetics market is driven by several factors…

Growth in the optogenetics market is driven by factors such as increasing neuroscience research, rising adoption of precision cell control tools, and continuous innovation in gene delivery and light activation technologies. Demand for advanced neurostimulation methods in academic and translational settings is pushing development of more efficient, customizable optogenetic tools.

The ability to integrate optogenetics with live imaging, behavioral assays, and electrophysiology is enhancing its role in systems biology. Rising investment in neural circuit mapping, psychiatric disorder research, and vision restoration technologies is reinforcing market expansion. Improvements in opsin sensitivity, expression control, and implantable light systems are broadening real-world applicability and sustaining momentum in both research and early clinical domains.

SCOPE OF STUDY:

The report analyzes the Optogenetics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Optogenetics Type (Type I Optogenetics, Type II Optogenetics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Addgene
  • Applied Genetic Technologies Corp.
  • Bruker Corporation
  • Bionic Sight LLC
  • Campden Instruments
  • Circuit Therapeutics Inc.
  • Cobolt Inc.
  • Coherent Inc.
  • Danaher Corporation
  • Elliot Scientific Ltd.
  • GenSight Biologics
  • GenScript Biotech Corporation
  • Hubner Photonics Inc.
  • Inscopix
  • Jackson Laboratory
  • Judges Scientific Plc
  • Laserglow Technologies
  • Lumentum Holdings Inc.
  • Merck KGaA
  • Mightex Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Optogenetics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Research in Neuroscience and Brain Mapping Spurs Adoption of Optogenetic Tools
    • Growing Investment in Precision Medicine Strengthens Business Case for Targeted Neural Modulation
    • Advancements in Light-Sensitive Proteins Propel Development of Next-Generation Optogenetic Constructs
    • Expansion of Cell-Type Specific Therapies Drives Demand for Genetically Encoded Optical Control Systems
    • Integration with CRISPR and Gene Editing Technologies Enhances Functional Versatility of Optogenetics
    • Surge in Demand for Non-Invasive Neuromodulation Techniques Throws the Spotlight on Optical Neural Control
    • Increasing Focus on Psychiatric and Neurodegenerative Disorders Expands Clinical Use Potential
    • Adoption of Fiber Optic Implant Systems Accelerates In Vivo Application of Optogenetics
    • Growth in Academic Collaborations and Open-Source Platforms Fuels Innovation and Accessibility
    • Emergence of Miniaturized Light Delivery Devices Strengthens Research Applications in Freely Moving Animals
    • Rising Use in Cardiac and Vision Research Opens New Avenues Beyond Neuroscience
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Optogenetics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Optogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Type I Optogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Type I Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Type II Optogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Type II Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 8: USA Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 9: USA 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • CANADA
    • TABLE 10: Canada Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 11: Canada 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • JAPAN
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 12: Japan Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 13: Japan 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • CHINA
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 14: China Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: China 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • EUROPE
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 16: Europe Recent Past, Current & Future Analysis for Optogenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: Europe 6-Year Perspective for Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 18: Europe Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: Europe 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • FRANCE
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 20: France Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: France 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • GERMANY
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 22: Germany Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Germany 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • ITALY
    • TABLE 24: Italy Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Italy 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • UNITED KINGDOM
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 26: UK Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: UK 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Rest of Europe 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 32: Rest of World Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Rest of World 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030

IV. COMPETITION